Skip to content
Slow
Bull
Companies
Exchanges
Sectors
Earnings calendar
News
Search companies
The market, slowly.
THURSDAY, 24 SEPTEMBER 2026
Companies
/
Healthcare
/
Pharmaceutical Preparations
C
Climb Bio, Inc.
CLYM
Nasdaq
SEC CIK 1768446
Follow Climb Bio
Weekly email: filings, results, news
Overview
News
5
Peers
News
5 stories filed under Climb Bio, grouped into ongoing threads
Phase data
Thread · 3 stories
BTIG raises Climb Bio stock price target to $32 on phase 1 data
Markets
21 d ago
Climb Bio reports phase 1 data for IgA nephropathy drug
Markets
21 d ago
Climb Bio and Mabworks begin dosing in Phase 2 trial for kidney disease in China
Markets
41 d ago
Trial
Thread · 2 stories
Baird raises Climb Bio stock price target to $25 on trial data
Markets
21 d ago
2 sources
Climb Bio stock surges 17% on positive drug trial results
Markets
21 d ago